RECALL ALERT: Sandoz and Novartis Prescription Drug Blister Packages Are Not Child-Resistant

The affected blister packs do not meet the requirements of the Poison Prevention Packaging Act

RECALL ALERT: Sandoz and Novartis Prescription Drug Blister Packages Are Not Child-Resistant
Image: CPSC
July 10, 2018

Sandoz and Novartis have implemented a nationwide recall for around 470,000 blister packages of prescription medication.

The affected blister packs are not child-resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk to young children.

Recalled Product Details

The recalled Novartis prescription blister packages have Novartis, along with the name of the drug, the dosage, NDC, lot number, and expiration date printed on the cartons and the blister cards.

The impacted Sandoz prescription blister packages have Sandoz, the name of the drug, dosage, NDC, and lot number printed on the cartons and the blister cards.

See a full list of the affected drugs and other identifying information for the recalled blister packs.

When and where were they sold?

Drugs packaged in the non-compliant blister packs were sold through clinics and pharmacies nationwide as a prescribed medicine from September 2016 to June 2018.

To date, there has been one report of a child ingesting a prescription drug linked to this recall.

What should consumers do?

Consumers should immediately secure the recalled blister packages to keep them out of the sight and reach of children. Contact Novartis or Sandoz at (888) 669-6682 for further instructions.

Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.